Evidence map›Paper›PMID 34520393›Full record

ArticleAging2021

UPF1 impacts on mTOR signaling pathway and autophagy in endometrioid endometrial carcinoma.

Minfen Zhang, Hui Chen, Ping Qin, Tonghui Cai, Lingjun Li, Ruichao Chen, Shaoyan Liu, Hui Chen, Wanrun Lin, Hao Chen and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Minfen ZhangDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Hui ChenDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Ping QinDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Tonghui CaiDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Lingjun LiDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Ruichao ChenDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Shaoyan LiuDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Hui ChenDepartment of Pathology, First Affiliated Hospital, Changsha 410005, China.
Wanrun LinDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Hao ChenDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Amanda L StricklandDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Hanzhen XiongDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Qingping JiangDepartment of Pathology, Third Affiliated Hospital, Guangzhou Medical University, Guangzhou 510150, China.
Guangzhou Medical University · CNThe First Hospital of Changsha · CNThird Affiliated Hospital of Guangzhou Medical University · CNNorthwestern University · USThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most EEC cases are associated with activities of the mTOR pathway, which regulates protein synthesis, cell growth and autophagy. While Up-Frameshift 1(UPF1) is a key protein factor in the nonsense-mediated mRNA degradation pathway (NMD), its role in carcinogenesis of EEC remains unclear. In this study, we first evaluated the expression level of UPF1 in EEC tissues and cell lines. Then, we investigated the effect of UPF1 on cellular function and mTOR signaling pathway; these effects were further validated

Indexed as

AnimalsCarcinoma, EndometrioidCell Line, TumorCell MovementCell ProliferationEndometrial NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansMiceMice, NudeNeoplasms, ExperimentalRNA HelicasesSignal TransductionTOR Serine-Threonine KinasesTrans-ActivatorsMTOR protein, humanRNA HelicasesTOR Serine-Threonine KinasesTrans-ActivatorsUPF1 protein, humanautophagyendometrioid endometrial carcinomamTORUPF1

Identifiers

PMID34520393
PMCPMC8457587
OpenAlexW3199498304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.